Evidence map›Paper›PMID 37794589›Full record

ArticleCell2023

SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.

Nora Schmidt, Sabina Ganskih, Yuanjie Wei, Alexander Gabel, Sebastian Zielinski, Hasmik Keshishian, Caleb A Lareau, Liv Zimmermann, Jana Makroczyova, Cadence Pearce and 21 more

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. LncRNAeLife · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 9 institutions in 2 countries.

Nora SchmidtHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Sabina GanskihHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Yuanjie WeiHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Alexander GabelHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Sebastian ZielinskiHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Hasmik KeshishianBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Caleb A LareauProgram in Computational and System Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Liv ZimmermannSchaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
Jana MakroczyovaSchaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
Cadence PearceBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Karsten KreySchool of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.
Thomas HennigInstitute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Sebastian StegmaierHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Lambert MoyonComputational Health Center, Helmholtz Center Munich, Munich, Germany.
Marc HorlacherComputational Health Center, Helmholtz Center Munich, Munich, Germany.
Simone WernerHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Jens AydinHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Marco Olguin-NavaHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Ramya PotabattulaInstitute of Human Genetics, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Anuja KibeHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Lars DölkenInstitute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Redmond P SmythHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Neva CaliskanHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany.
Annalisa MarsicoComputational Health Center, Helmholtz Center Munich, Munich, Germany.
Christine KremplInstitute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Jochen BodemInstitute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Andreas PichlmairSchool of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany; German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.
Steven A CarrBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Petr ChlandaSchaller Research Group, Department of Infectious Diseases, Virology, Heidelberg University Hospital, Heidelberg, Germany.
Florian ErhardInstitute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Germany; Faculty for Computer and Data Science, University of Regensburg, Regensburg, Germany.
Mathias MunschauerHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), Würzburg, Germany; Faculty of Medicine, Julius-Maximilians-University Würzburg, Würzburg, Germany. Electronic address: mathias.munschauer@helmholtz-hiri.de.
Helmholtz Centre for Infection Research · DEUniversity of Würzburg · DEHelmholtz Institute for RNA-based Infection Research · DEBroad Institute · USHelmholtz Zentrum München · DEHeidelberg University · DETechnical University of Munich · DEMemorial Sloan Kettering Cancer Center · USUniversity Hospital Heidelberg · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Charting somatic evolution via single-cell multiomicsK99HG012579 · NHGRI · STANFORD UNIVERSITY · PI LAREAU, CALEB ANDREW · 2022 to 2022
$119k
European Research Council 101040914NCI NIH HHS P30 CA008748NHGRI NIH HHS K99 HG012579
6 · The paper itself

Abstract

Regulation of viral RNA biogenesis is fundamental to productive SARS-CoV-2 infection. To characterize host RNA-binding proteins (RBPs) involved in this process, we biochemically identified proteins bound to genomic and subgenomic SARS-CoV-2 RNAs. We find that the host protein SND1 binds the 5' end of negative-sense viral RNA and is required for SARS-CoV-2 RNA synthesis. SND1-depleted cells form smaller replication organelles and display diminished virus growth kinetics. We discover that NSP9, a viral RBP and direct SND1 interaction partner, is covalently linked to the 5' ends of positive- and negative-sense RNAs produced during infection. These linkages occur at replication-transcription initiation sites, consistent with NSP9 priming viral RNA synthesis. Mechanistically, SND1 remodels NSP9 occupancy and alters the covalent linkage of NSP9 to initiating nucleotides in viral RNA. Our findings implicate NSP9 in the initiation of SARS-CoV-2 RNA synthesis and unravel an unsuspected role of a cellular protein in orchestrating viral RNA production.

Indexed as

COVID-19RNA, ViralEndonucleasesHumansRNA-Binding ProteinsSARS-CoV-2Viral ProteinsVirus ReplicationEndonucleasesnsp9 protein, SARS virusRNA-Binding ProteinsRNA, ViralSND1 protein, humanViral Proteinshost factorsomics technologiesproteomicsRNA binding proteinsRNA biologyRNA interactomeRNA virusSARS-CoV-2systems biologyvirus host interactions

Identifiers

PMID37794589
PMCPMC10617981
OpenAlexW4387311913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.